Espin-AT Tablet is a combination medication containing S-Amlodipine 2.5 mg and Atenolol 50 mg, primarily used for the management of hypertension and angina pectoris. S-Amlodipine, a calcium channel blocker, works by relaxing blood vessels, thereby reducing the workload on the heart and lowering blood pressure. Atenolol, a selective beta-1 blocker, decreases heart rate and cardiac output, further aiding in blood pressure control and prevention of angina attacks. This synergistic action helps in effectively controlling high blood pressure, reducing the risk of cardiovascular events such as stroke and heart attack. Espin-AT is typically prescribed when monotherapy with either agent is insufficient to achieve desired blood pressure targets. It is important to take this medication exactly as directed by a healthcare professional, usually once daily, with or without food. Common side effects may include dizziness, fatigue, and mild swelling of the ankles. Patients with asthma, severe bradycardia, or certain heart conduction disorders should avoid this medication unless advised otherwise by their physician. Regular monitoring of blood pressure and heart rate is recommended during treatment to ensure optimal therapeutic outcomes and minimize potential adverse effects.